Journal of Neuroscience Research · 1991 · 1.2K citations · 30 references
Life SciencesImmunologyNeuroscienceCellular ImmunologyInflammationNeuroimmunologyCell-mediated ImmunityCentral Nervous System ImmunityLymphocyte ActivationLymphocyte TraffickingT Cell ActivationT Cell BiologyActivationT Cell ImmunologyT Cell-mediated InflammationT-cell Mediated ResponsesT-cell Receptor Gene UsageT-cell Trafficking
The entry of T‑lymphocytes into CNS parenchyma is a key early event in many immune‑mediated diseases, yet the physiological mechanisms governing this process remain unclear. In rats, T‑cell CNS entry is largely determined by lymphocyte activation state—activated lymphoblasts enter rapidly, peak at 9–12 h, and exit within 1–2 days, while non‑activated cells are excluded, and antigen‑specific cells persist or reenter to drive inflammation, independent of antigen specificity, MHC compatibility, phenotype, or TCR usage.
Abstract The entry of T‐lymphocytes into the parenchyma of the central nervous system is a critical early feature in the pathogenesis of many experimental and spontaneously occurring immune‐mediated illnesses. The physiological mechanisms controlling this entry have not been elucidated. This study reports that T‐cell entry into the rat CNS appears to be primarily dependent upon the activation state of the lymphocytes; T‐lymphoblasts enter the CNS (and all other tissues examined) in an apparently random manner while T cells not in blast phase are excluded. Antigen specificity, MHC compatibility, T‐cell phenotypce and T‐cell receptor gene usage do not appear related to the ability of cells to enter. This study demonstrates that when T‐lymphoblasts are introduced into the circulation they rapidly appear in the CNS tissue. Their concentration in the CNS reaches a peak between 9 and 12 hr, and lymphocytes which have entered, exit within 1 to 2 days. Cells capable of reacting with a CNS antigen remain in the tissue or cyclically reenter to initiate inflammation if they are able to recognize their antigen in the correct MHC context. This observation also appears to pertain to the entry of activated T cells into many other tissues, although their concentrations in these non‐CNS sites was not quantitatied.
30
Immunologically Privileged Sites
Clyde F. Barker, R. E. Billingham · Advances in immunology · 1978 · 812 citations
Cellular immune reactivity within the CNS
Hartmut Wekerle, Christopher Linington, Hans Lassmann et al. · Trends in Neurosciences · 1986 · 770 citations